The Impact of Current Staging Procedures in Assessing Disease Extent of Prostatic Adenocarcinoma

Abstract

Patients [454] with prostatic adenocarcinoma were assigned a preliminary clinical stage on the basis of serum acid phosphatase, routine bone survey and physical examination. Subsequently, they were assigned a final clinical stage after radioisotopic bone scanning, lymphangiography and staging pelvic lymph node dissection. Only 53, 54, 57 and 26%, respectively, of patients initially assigned the preliminary clinical stage of IBB, II, III or IVA remained at that stage after the additional studies.